Biocompatibility Between Phbhhx Films Modified By Phap-Rgd Fusion Protein And Human Nasal Septum Chondrocytes

Zheng-Hui Wang,Min-Jie Fan,Xiao-Li Li,Qing Zhang,Hua-Nan Luo,Ying Gao,Guo-Xi Zheng,Jin Hou,Bo-Tao Wang,Xiao-Peng Li,Jian-Min Liang,Xiao-Yan Zhao,Min Xu
2016-01-01
Abstract:Objective: We discussed the biocompatibility between PHBHHx films modified by PhaP-RGD fusion protein and human nasal septum chondrocytes. Method: Human nasal septum chondrocytes cultured in vitro were inoculated to PHBHHx films modified by PhaP-RGD fusion protein for cultivation for 3 d and 7 d, respectively. Biocompatibility between PHBHHx films modified by PhaP-RGD fusion protein and human nasal septum chondrocytes was characterized by MTT colorimetry assay, DAPI staining, scanning electron microscopy and toluidine blue staining. Results: The water contact angle of PHBHHx films modified by PhaP-RGD fusion protein decreased and the hydrophilicity increased. Human nasal septum chondrocytes maintained a high proliferation rate on the films modified by PhaP-RGD fusion protein. After in vitro culture for 3 d, the chondrocytes growing on the modified films had a significantly higher viability than those on unmodified films. Toluidine blue staining revealed that PHBHHx films modified by PhaPRGD fusion protein promoted the secretion of extracellular matrix glycosaminoglycans by chondrocytes. Conclusion: PHBHHx films modified by PhaP-RGD fusion protein had a better biocompatibility with chondrocytes. Therefore, modification by PhaP-RGD fusion protein represented a good surface biomodification method.
What problem does this paper attempt to address?